|Project Title||Parkinson’s Disease Medication Use|
Friday, June 7, 2013
Modular program-based one-time assessment of the use of three different drugs for Parkinson’s Disease, carbidopa/levodopa, entacapone, and combination product carbidopa, levodopa, and entacapone (Stalevo), in the Mini-Sentinel Distributed Database. Two categories of counts were generated: (1) incident counts with respect to each of the medications, and (2) prevalent counts (i.e., counts of users with at least one dispensing during the period of interest [January 2000- December 2010]). Modular programs are adaptable standardized programs. Results were generated using Modular Program 1; click here for more information. Programs were executed in February 2011.
If you are using a web page screen reader and are unable to access this document, please contact the Mini-Sentinel Operations Center for assistance by clicking on the Submit Comments link above or sending an email requesting assistance to email@example.com.
The information contained on this website is provided as part of FDA's commitment to place knowledge acquired from the Mini-Sentinel pilot in the public domain as soon as possible. Please read the disclaimer.
combination product of carbidopa
levodopa and entacapone (Stalevo)
|Population / Cohort||
January 1, 2000 - December 31, 2010
Mini-Sentinel Distributed Database (MSDD)
- Vaccines, Blood & Biologics
- Devices and Radiologic Health